Pacific Biosciences of California, Inc.
Stock Details
Is it expensive?
Trailing P/E Ratio
-0.79
Forward P/E Ratio
-3.43
PEG Ratio
0.00
-5.03
Price-to-Sales (TTM)
2.67
78.61
0.02
Market Cap
434.88M
851.75M
Is it profitable?
Net Profit Margin (TTM)
28.61%
Gross Profit Margin
37.11%
Diluted EPS (TTM)
-1.82
-213.45%
160.00M
Is it growing?
13.80%
13.82%
Is it risky?
2.33
13.13K
5.15
702.42M
Who owns it?
59.44%
9.33%
15.58%
301.96M
293.75M
Does it pay?
0.00%
0.00%
--
--
How much cash?
279.51M
-111.21M
97.55M
0.93
- Price
- 1.47
- Percent Change
- +0.03 (2.08%)
- Previous Close
- 1.44
- Open
- 1.56
- Low
- 1.44
- High
- 1.59
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$1.47
From 52W Low
+72.94%
From 52W High
-46.15%
Today
+2.08%
1Y Change
+1.38%
6M
$1.53
3M
$1.94
1M
$1.39
Today
$1.47
From 52W Low
+72.94%
From 52W High
-46.15%
Today
+2.08%
1Y Change
+1.38%
6M
$1.53
3M
$1.94
1M
$1.39
Today
$1.47
Below Average
within its 1-year price range
$1.47
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+5.8%
3M
-24.2%
6M
-3.9%
1Y
+1.4%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Pacific Biosciences of California, Inc.
- Founded
- Jan 1, 2004
- Founders
- Stephen Turner, Joseph DeSimone
- CEO
- Christian O. Henry
- Employees
- 485
- Fiscal Year End
- Dec 31, 2025
- Address
1305 O'Brien Drive
Menlo Park
California
94025
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.pacb.com
Indicators
Operating Cash Flow
-111.21M
Net Income
-546.38M
Paper Profits
0.20
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Indicators
Operating Cash Flow
-111.21M
Net Income
-546.38M
Paper Profits
0.20
Company reports significant profit, but very little cash is actually coming in. This pattern has historically preceded earnings corrections and dividend cuts.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Trailing P/E Ratio
-0.79
Forward P/E Ratio
-3.43
PEG Ratio
0.00
-5.03
Price-to-Sales (TTM)
2.67
78.61
0.02
Market Cap
434.88M
851.75M
Is it profitable?
Net Profit Margin (TTM)
28.61%
Gross Profit Margin
37.11%
Diluted EPS (TTM)
-1.82
-213.45%
160.00M
Is it growing?
13.80%
13.82%
Is it risky?
2.33
13.13K
5.15
702.42M
Who owns it?
59.44%
9.33%
15.58%
301.96M
293.75M
Does it pay?
0.00%
0.00%
--
--
How much cash?
279.51M
-111.21M
97.55M
0.93
- Price
- 1.47
- Percent Change
- +0.03 (2.08%)
- Previous Close
- 1.44
- Open
- 1.56
- Low
- 1.44
- High
- 1.59
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
$1.47
From 52W Low
+72.94%
From 52W High
-46.15%
Today
+2.08%
1Y Change
+1.38%
6M
$1.53
3M
$1.94
1M
$1.39
Today
$1.47
From 52W Low
+72.94%
From 52W High
-46.15%
Today
+2.08%
1Y Change
+1.38%
6M
$1.53
3M
$1.94
1M
$1.39
Today
$1.47
Below Average
within its 1-year price range
$1.47
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+5.8%
3M
-24.2%
6M
-3.9%
1Y
+1.4%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Low Volume
Very little activity today. Thin trading can exaggerate price moves in either direction. As reflected in the Relative Volume (RVOL) below.
- Name
- Pacific Biosciences of California, Inc.
- Founded
- Jan 1, 2004
- Founders
- Stephen Turner, Joseph DeSimone
- CEO
- Christian O. Henry
- Employees
- 485
- Fiscal Year End
- Dec 31, 2025
- Address
1305 O'Brien Drive
Menlo Park
California
94025
United States
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Life Sciences Tools & Services
- Website
- www.pacb.com